Ligand validation:6SKB

LH5: 4-[(3~{S})-1-oxidanyl-3,4-dihydro-2,1-benzoxaborinin-3-yl]-2-(pyridin-3-ylmethoxy)benzenecarboximidamide

LH5 is a Ligand Of Interest in 6SKB designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6SKB_LH5_A_301	56%	71%	0.143	0.913	0.51	0.59	-	-	0	0	100%	0.5
6SKB_LH5_C_302	51%	66%	0.133	0.888	0.51	0.78	-	1	0	0	100%	0.5
6SKB_LH5_B_301	20%	70%	0.193	0.795	0.51	0.63	-	-	0	0	100%	0.5

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.